IT Officials Raid Akums Offices, Top Execs’ Residences

Mumbai:  Pharmaceutical company Akums Drugs and Pharmaceuticals Ltd on Thursday (January 23) announced that the Income Tax (I-T) Department conducted a search and survey operation at its offices, manufacturing units, and the residences of its managing directors and chief financial officer.

The I-T Department’s search operation took place between January 15-21, 2025. During this period, the I-T officials sought various clarifications and details from the company, to which Akums Drugs extended full cooperation.

“The IT Department conducted a search under the Income Tax Act, 1961 at the offices and manufacturing units of the Company, its subsidiaries and the residences of the managing directors and chief financial officer of the company from January 15, 2025, till 11:00 pm on January 21, 2025,” Akums Drugs and Pharmaceuticals said in a regulatory filing.

The company has not received any written communication from the I-T Department regarding the outcome of the search or any alleged violations/ contraventions. Additionally, no financial demand has been raised by the department so far.

“The company extended full cooperation to the officials of the IT Department during the search and responded to all clarifications and details sought by them,” it said.

Akums Drugs has stated that its business operations continue as usual, except for some minor disruptions during the search operation. “The business operations of the Company continue as usual except for some minor hiccups and no financial demand has been raised by the Deptt. so far,” it added.

SOURCE : CNBC TV18

Related Posts

  • Pharma
  • July 22, 2025
  • 135 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 562 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug